低HER2乳腺癌:唾液代谢特征和治疗前景
1Biochemistry Research Laboratory, Omsk State Pedagogical University, 644099 Omsk, Russia.
Frontiers in bioscience (Scholar edition)
|July 4, 2025
概括
低HER2乳腺癌亚组表现出明显的免疫和代谢特征,炎症加剧和氨基酸水平发生变化. 这一发现突显了HER2低乳腺癌的独特特征,可能指导新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
背景情况:
- 低HER2乳腺癌的代谢和免疫特征在很大程度上仍未被描述.
- 这项研究调查了HER2-低乳腺癌中的免疫反应,瘤标志物和氨基酸概况.
研究的目的:
- 确定HER2-低乳腺癌独特的代谢和免疫特征.
- 为 HER2 低乳腺癌患者确定潜在的新治疗点.
主要方法:
- 一项病例控制研究分析了660名未经治疗的乳腺癌患者的唾液.
- 测量了细胞因子,瘤标记物,氨基酸和生物化学参数的度.
主要成果:
- 低HER2组显示出最高的促炎和最低的代谢活性.
- 在HER2-低子组中观察到三个功能性氨基酸组的显著差异.
- 癌症抗原19-9 (CA 19-9) 在HER2-低组中显示出最显著的偏差.
结论:
- 低HER2的乳腺癌患者具有不同的疾病进展,免疫反应和代谢活动概况.
- 了解这些代谢特征可能会揭示HER2-低子组的新疗法标.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


